Shangwei Sun, Yang Hu, Ling Lan, Yang Li, Zhong Wu, Jiehui Deng, Adam J Bass, Yahui Zhao, Zhihua Liu, Jin Zhou. "A phase I dose-escalation study to evaluate safety and feasibility of neoadjuvant camrelizumab with palbociclib for the treatment of resectable esophageal squamous cell carcinoma (ESCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16114